Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD8835 + AZD9496 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD8835 | AZD-8835|AZD 8835 | PIK3CA inhibitor 24 PIK3CD inhibitor 27 | AZD8835 inhibits PIK3CA and PIK3CD, potentially resulting in decreased growth of PI3K-dependent tumors (PMID: 26839307, PMID: 32194423). | |
AZD9496 | AZD-9496|AZD 9496 | Hormone - Anti-estrogens 29 | AZD9496 is a selective degrader of estrogen receptor, which leads to growth inhibition of ER-positive tumors (PMID: 32609836, PMID: 32461092, PMID: 32234755). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|